-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JXyIXSJYLj6FzzN3fjs67wLFKhZ1uxxOX9YC2IcJgu+ttHx2fDF55Gd11h19psKg hd/UX6fd/l6T2A0/LRGYKg== 0001016193-09-000007.txt : 20090512 0001016193-09-000007.hdr.sgml : 20090512 20090512152258 ACCESSION NUMBER: 0001016193-09-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090512 DATE AS OF CHANGE: 20090512 EFFECTIVENESS DATE: 20090512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-MISCELLANEOUS SHOPPING GOODS STORES [5940] IRS NUMBER: 870652870 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-124542 FILM NUMBER: 09818558 BUSINESS ADDRESS: STREET 1: 3293 HARRISON BOULEVARD STE 230 CITY: OGDEN STATE: UT ZIP: 84403 BUSINESS PHONE: 8013995500 MAIL ADDRESS: STREET 1: 3293 HARRISON BOULEVARD STE 230 CITY: OGDEN STATE: UT ZIP: 84403 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 D 1 primary_doc.xml X0301 D LIVE 0001133818 BIO-PATH HOLDINGS INC 3293 HARRISON BOULEVARD STE 230 OGDEN UT 84403 8013995500 OGDEN GOLF CO CORP UT Corporation true Peter H Nielsen 3293 Harrison Blvd Ste 230 Ogden UT 84403 Executive Officer Director Promoter Douglas P Morris 3293 Harrison Blvd Ste 230 Ogden UT 84403 Executive Officer Director Promoter Thomas Garrison 3293 Harrison Blvd Ste 230 Ogden UT 84403 Director Gillian Ivers-Read 3293 Harrison Blvd Ste 230 Ogden UT 84403 Director Biotechnology No Revenues 06 false true false true false 0 ACAP Financial Inc. 07731 None None 57 West 200 South Ste 202 Salt Lake City UT 84101 AZ 500000 0 500000 Units of two shares of common stock and two warrants. false 0 50000 true 0 Plus one share of stock for each five units sold. 0 true Clinical trials - $400,000 - $42,000 G&A. false BIO-PATH HOLDINGS INC Douglas P. Morris Douglas M. Morris Vice President 2009-05-12 -----END PRIVACY-ENHANCED MESSAGE-----